{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:53:44Z","timestamp":1790952824713,"version":"4.1.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,10,15]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>We evaluated the safety outcomes of opioids alone versus opioids plus low-dose gabapentinoids in patients na\u00efve to both opioids and gabapentinoids, after total joint arthroplasty (TJA) of the knee, hip, or shoulder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a multicenter, population-based, retrospective cohort study based in a large, integrated health system. It included opioid-na\u00efve and gabapentinoid-na\u00efve patients who underwent TJA between 2018 and 2024. Patients were categorized into two groups: those dispensed opioids and low-dose gabapentinoids or those dispensed opioids alone postoperatively. The primary outcome was opioid-related overdose events. The secondary outcome was adverse events, including falls, fractures, neurologic\/cognitive changes, sedation, and delirium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 36,351 consecutive patients comprised the study cohort, including 29,009 (79.8%) in the opioids-alone group and 7,342 (20.2%) in the opioids plus gabapentinoids group. In total, there were 19 (0.05% total cohort) opioid-related overdose events. Fourteen of these (0.05%) were in the opioids-alone group, and five (0.07%) were in the opioids plus gabapentinoids group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.3). In addition, 233 patients (0.6%) experienced emergency department or hospital admission due to an adverse event, including 200 patients (0.69%) in the opioids-alone group and 33 patients (0.45%) in the opioids plus gabapentinoids group. No statistically significant difference in adverse event risk was identified between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Concurrent prescriptions for opioids and low-dose gabapentinoids after TJA were not associated with a statistically significant difference in risk of emergency department or hospital readmission due to opioid-related overdose or adverse events compared with opioids alone. However, the rarity of overdose events limits statistical power, and these findings should be interpreted cautiously.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-01651","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:08:47Z","timestamp":1779887327000},"page":"e2948-e2956","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Risk of Overdose and Adverse Events With Concomitant Opioids and Gabapentinoid Use After Total Joint Arthroplasty"],"prefix":"10.5435","volume":"34","author":[{"given":"Paolo Tristian","family":"Domingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8389-0691","authenticated-orcid":false,"given":"Garrett K.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Chaput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshuman","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","article-title":"Management of postoperative pain: A Clinical Practice Guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists\u2019 Committee on Regional Anesthesia, Executive Committee, and Administrative Council","volume":"17","author":"Chou","year":"2016","journal-title":"J Pain"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"NP1769","DOI":"10.1093\/asj\/sjab288","article-title":"The nuts and bolts of a successful non-narcotic perioperative enhanced recovery after surgery protocol","volume":"41","author":"Schultz","year":"2021","journal-title":"Aesthet Surg J"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bpa.2019.07.016","article-title":"Postoperative pain management in the era of ERAS: An overview","volume":"33","author":"Joshi","year":"2019","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s11606-019-05545-y","article-title":"Risk of overdose with exposure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: A retrospective cohort study","volume":"35","author":"Cho","year":"2020","journal-title":"J Gen Intern Med"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"e2031647","DOI":"10.1001\/jamanetworkopen.2020.31647","article-title":"Association of gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States","volume":"3","author":"Bykov","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/ajad.13022","article-title":"Incidence of postoperative opioid overdose and new diagnosis of opioid use disorder among US veterans","volume":"29","author":"Siglin","year":"2020","journal-title":"Am J Addict"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for prescribing opioids for pain\u2014United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/cpt.2314","article-title":"Coprescription of opioids with other medications and risk of opioid overdose","volume":"110","author":"Khan","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"R11-20261002","first-page":"100302","article-title":"Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control study","volume":"13","author":"Olopoenia","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"732","DOI":"10.7326\/M18-1136","article-title":"Pregabalin and the risk for opioid-related death: A nested case\u2013control study","volume":"169","author":"Gomes","year":"2018","journal-title":"Ann Intern Med"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"e1002396","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case\u2013control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1213\/ANE.0000000000001719","article-title":"Multimodal analgesic therapy with gabapentin and its association with postoperative respiratory depression","volume":"125","author":"Cavalcante","year":"2017","journal-title":"Anesth Analgesia"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40264-017-0595-1","article-title":"All-cause and drug-related medical events associated with overuse of gabapentin and\/or opioid medications: A retrospective cohort analysis of a commercially insured US population","volume":"41","author":"Peckham","year":"2018","journal-title":"Drug Saf"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:00:20Z","timestamp":1790949620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":13,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-01651","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2025-12-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}